(Q71810390)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587422%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Rapid onset of tolerance to the bronchoprotective effect of salmeterol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587422%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Rapid Onset of Tolerance to the Bronchoprotective Effect of Salmeterol (English)

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

26 May 2024

author name string

R. Bhagat

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7587422

26 May 2024

S. Kalra

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7587422

26 May 2024

V. A. Swystun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7587422

26 May 2024

D. W. Cockcroft

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7587422

26 May 2024

language of work or name

English

0 references

publication date

1 November 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587422%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 October 2019

https://api.elsevier.com/content/article/PII:S0012369216356963?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

https://api.elsevier.com/content/article/PII:S0012369216356963?httpAccept=text/plain

26 May 2024

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

26 May 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587422%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587422%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587422%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

1235-1239

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587422%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Long- versus short-acting beta 2-agonists. Implications for drug therapy

26 May 2024

2

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Regular inhaled beta-agonist treatment in bronchial asthma.

26 May 2024

3

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Regular inhaled salbutamol and airway responsiveness to allergen

26 May 2024

4

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma

26 May 2024

5

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma

26 May 2024

6

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline

26 May 2024

7

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma

26 May 2024

8

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Bronchial reactivity to inhaled histamine: a method and clinical survey

26 May 2024

9

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Determination of histamine PC20. Comparison of linear and logarithmic interpolation.

26 May 2024

10

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Regular use of inhaled albuterol and the allergen-induced late asthmatic response

26 May 2024

11

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients

26 May 2024

15

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Changes in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients

26 May 2024

16

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma

26 May 2024

17

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Airway responsiveness to histamine as a test for overall severity of asthma in children

26 May 2024

18

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment

26 May 2024

19

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Bronchodilator treatment in asthma. Manufacturers underestimate mortality from asthma

26 May 2024

20

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Bronchodilator treatment in asthma

26 May 2024

22

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Respiratory arrests in young asthmatics on salmeterol

26 May 2024

23

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

26 May 2024

Risks of salmeterol?

24

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Are there any detrimental effects of the use of inhaled long-acting beta 2-agonists in the treatment of asthma?

26 May 2024

25

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study

26 May 2024

26

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81

26 May 2024

27

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study

26 May 2024

28

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

The use of beta-agonists and the risk of death and near death from asthma

26 May 2024

29

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity?

26 May 2024

30

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists

26 May 2024

31

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Beta 2-agonists and their antagonists

26 May 2024

32

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

Perspectives in beta 2-agonist therapy: vox clamantis in deserto vel lux in tenebris?

26 May 2024

33

1 reference

https://api.crossref.org/works/10.1378/CHEST.108.5.1235

26 May 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587422%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference